The Perelman School of Medicine’s Pablo Tebas spoke about his research, which used a zinc finger nucleases, a precursor to CRISPR, to modify white blood cells and reinfuse them into patients. While not a cure for HIV, combined with other methods, this approach “might be the way of the future,” said Tebas.

March 4, 2019 ・ From Science